Luming Wu
Overview
Explore the profile of Luming Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma S, Wu L, Ye L, Habra M, Balderrama-Brondani V, Wang W
Endocrine
. 2025 Jan;
PMID: 39862362
Purpose: Adrenocortical carcinoma (ACC) is a rare malignancy known for high rates of recurrence and poor prognosis. Previous studies revealed controversial roles of adjuvant radiation therapy (RT) in patient management....
2.
Jiang Y, Zhou L, Zhang C, Su T, Jiang L, Zhou W, et al.
Endocr Pract
. 2024 Sep;
30(12):1180-1187.
PMID: 39260773
Objective: Mineralocorticoid receptor antagonists are the recommended medical therapy for bilateral primary aldosteronism (BPA). Patients with BPA have higher risk of cardiocerebrovascular disease (CCVD) than those with essential hypertension. There...
3.
Wu L, Zhan Y, Wang Y
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38892384
The purpose of this study was to explore the effect of Semaglutide on intrauterine adhesions and discover new drugs for such adhesions. In this study, the cell model was simulated...
4.
Zhang J, Wu L, Su T, Liu H, Jiang L, Jiang Y, et al.
Front Endocrinol (Lausanne)
. 2024 May;
15:1365321.
PMID: 38779454
Background: Adrenocortical carcinoma (ACC) is an aggressive endocrine malignancy with limited therapeutic options. Treating advanced ACC with mitotane, the cornerstone therapy, remains challenging, thus underscoring the significance to predict mitotane...
5.
Jiang Y, Zhou L, Zhang C, Su T, Jiang L, Zhou W, et al.
Front Endocrinol (Lausanne)
. 2024 May;
15:1369582.
PMID: 38745957
Context: The prevalence of unilateral primary aldosteronism (UPA) with cortisol co-secretion varies geographically. Objective: To investigate the prevalence and clinical characteristics of UPA with cortisol co-secretion in a Chinese population....
6.
Wu L, Xie J, Qi Y, Su T, Jiang L, Zhou W, et al.
Endocr Relat Cancer
. 2024 Jan;
31(3).
PMID: 38284820
No abstract available.
7.
Wu L, Chen J, Su T, Jiang L, Han Y, Zhang C, et al.
Front Endocrinol (Lausanne)
. 2024 Jan;
14:1308231.
PMID: 38260140
Context: Adrenocortical carcinoma (ACC) is rare and have high rates of recurrence and mortality. The role of adjuvant radiation therapy (RT) in localized ACC was controversial. Methods: We conducted a...
8.
Wu J, Zhou T, Shen H, Jiang Y, Yang Q, Su S, et al.
Ecotoxicol Environ Saf
. 2024 Jan;
270:115922.
PMID: 38171106
Bisphenol A (BPA), an environmental endocrine disruptor (EDC), has been implicated in impairing intestinal and male reproductive dysfunction. The efficacy of gut microbiota modulation for BPA-exposed testicular dysfunction has yet...
9.
Zhang M, Shi Z, Wu C, Yang F, Su T, Jing X, et al.
J Clin Endocrinol Metab
. 2023 Dec;
109(6):1474-1484.
PMID: 38157274
Context: Cushing syndrome (CS) is a severe endocrine disease characterized by excessive secretion of cortisol with multiple metabolic disorders. While gut microbial dysbiosis plays a vital role in metabolic disorders,...
10.
Tang J, Li J, Lian J, Huang Y, Zhang Y, Lu Y, et al.
J Adv Res
. 2023 Sep;
61:239-251.
PMID: 37734566
Introduction: Despite radiotherapy being one of the major treatments for triple-negative breast cancer (TNBC), new molecular targets for its treatment are still required due to radioresistance. CDK2 plays a critical...